Cite
HARVARD Citation
Yacyshyn, B. et al. (2002). Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Gut. 51 (1), pp. 30-36. [Online].